66.06
price up icon2.05%   1.33
after-market 시간 외 거래: 65.91 -0.15 -0.23%
loading
전일 마감가:
$64.73
열려 있는:
$66.48
하루 거래량:
8.06M
Relative Volume:
0.95
시가총액:
$293.24B
수익:
$42.09B
순이익/손실:
$14.65B
주가수익비율:
20.12
EPS:
3.2833
순현금흐름:
$10.11B
1주 성능:
+3.80%
1개월 성능:
-14.37%
6개월 성능:
-44.85%
1년 성능:
-46.94%
1일 변동 폭
Value
$65.33
$66.75
1주일 범위
Value
$59.32
$66.75
52주 변동 폭
Value
$59.32
$148.15

노보 노디스크 Stock (NVO) Company Profile

Name
명칭
Novo Nordisk Adr
Name
전화
-
Name
주소
-
Name
직원
76,302
Name
트위터
@novonordisk
Name
다음 수익 날짜
2024-12-06
Name
최신 SEC 제출 서류
Name
NVO's Discussions on Twitter

NVO을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Drug Manufacturers - General icon
NVO
Novo Nordisk Adr
66.06 293.24B 42.09B 14.65B 10.11B 3.2833
Drug Manufacturers - General icon
LLY
Lilly Eli Co
754.35 677.53B 45.04B 10.59B 414.30M 11.71
Drug Manufacturers - General icon
JNJ
Johnson Johnson
154.36 344.63B 88.82B 14.07B 18.06B 5.79
Drug Manufacturers - General icon
ABBV
Abbvie Inc
179.10 316.82B 56.33B 4.28B 17.83B 2.40
Drug Manufacturers - General icon
NVS
Novartis Ag Adr
109.46 216.19B 51.72B 11.94B 13.81B 5.88

노보 노디스크 Stock (NVO) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2025-03-13 업그레이드 Kepler Hold → Buy
2025-03-03 다운그레이드 Stifel Buy → Hold
2025-02-12 개시 Morgan Stanley Equal-Weight
2025-01-06 업그레이드 Bernstein Underperform → Mkt Perform
2024-05-30 개시 Goldman Buy
2024-04-12 개시 BMO Capital Markets Outperform
2024-01-23 개시 Morgan Stanley Overweight
2024-01-16 재개 UBS Neutral
2023-12-01 개시 Cantor Fitzgerald Overweight
2023-10-02 개시 Argus Buy
2023-07-14 개시 HSBC Securities Buy
2022-07-15 업그레이드 Morgan Stanley Equal-Weight → Overweight
2022-06-28 다운그레이드 UBS Neutral → Sell
2022-06-27 업그레이드 Exane BNP Paribas Underperform → Neutral
2022-06-07 업그레이드 JP Morgan Neutral → Overweight
2022-05-31 업그레이드 Guggenheim Neutral → Buy
2022-04-25 업그레이드 Cowen Market Perform → Outperform
2022-04-12 업그레이드 Morgan Stanley Underweight → Equal-Weight
2022-03-16 업그레이드 Deutsche Bank Hold → Buy
2022-01-25 다운그레이드 Liberum Hold → Sell
2021-12-20 다운그레이드 JP Morgan Overweight → Neutral
2021-12-17 다운그레이드 Deutsche Bank Buy → Hold
2021-01-20 다운그레이드 Credit Suisse Outperform → Neutral
2021-01-15 개시 Deutsche Bank Buy
2020-09-29 개시 Berenberg Hold
2020-07-06 다운그레이드 BofA Securities Buy → Neutral
2020-05-11 다운그레이드 UBS Buy → Neutral
2020-05-04 개시 Cowen Market Perform
2020-03-16 업그레이드 BofA/Merrill Neutral → Buy
2020-01-03 다운그레이드 Guggenheim Buy → Neutral
2019-11-18 업그레이드 Barclays Equal Weight → Overweight
2019-09-17 업그레이드 Citigroup Neutral → Buy
2019-08-30 다운그레이드 Jefferies Hold → Underperform
2019-06-20 다운그레이드 Deutsche Bank Buy → Hold
2019-06-11 업그레이드 Barclays Underweight → Equal Weight
2019-04-29 업그레이드 Credit Suisse Neutral → Outperform
2019-01-29 개시 Exane BNP Paribas Outperform
2018-12-11 재개 Jefferies Hold
2018-10-09 개시 Guggenheim Buy
2017-12-29 업그레이드 JP Morgan Underweight → Neutral
2017-12-06 업그레이드 BofA/Merrill Neutral → Buy
2017-12-01 업그레이드 Morgan Stanley Equal-Weight → Overweight
2017-09-25 다운그레이드 Exane BNP Paribas Outperform → Neutral
2017-09-06 업그레이드 BofA/Merrill Underperform → Neutral
모두보기

노보 노디스크 주식(NVO)의 최신 뉴스

pulisher
11:12 AM

Why Eli Lilly, Novo Nordisk, and Viking Therapeutics Stocks All Popped Today - The Motley Fool

11:12 AM
pulisher
Apr 09, 2025

Is Novo Nordisk Stock a Buy After its Collapse? - Morningstar

Apr 09, 2025
pulisher
Mar 28, 2025

Is Novo Nordisk (NVO) the Best ADR Stock to Buy According to Hedge Funds? - Insider Monkey

Mar 28, 2025
pulisher
Mar 28, 2025

Novo Nordisk’s $2B deal for obesity drug a strategic game-changer for US pharmaceutical market - Yahoo Finance

Mar 28, 2025
pulisher
Mar 27, 2025

Why Novo Nordisk Stock Dipped on Thursday - Yahoo Finance

Mar 27, 2025
pulisher
Mar 15, 2025

Novo Nordis Share Price | NYSE: NVO Stock - Investing.com UK

Mar 15, 2025
pulisher
Mar 11, 2025

INVESTOR ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Lawsuit Against Novo Nordisk A/SNVO - Finansavisen

Mar 11, 2025
pulisher
Mar 10, 2025

Novo Nordisk shares plunge after obesity drug trial - The Irish Independent

Mar 10, 2025
pulisher
Mar 07, 2025

Novo Nordisk AS (NVO) Stock Price, Trades & News - GuruFocus.com

Mar 07, 2025
pulisher
Mar 06, 2025

Novo Nordisk A/S Sponsored ADR Class B to Host Earnings Call - ACCESS Newswire

Mar 06, 2025
pulisher
Mar 06, 2025

NVO Stock Quote Price and Forecast - CNN

Mar 06, 2025
pulisher
Mar 04, 2025

META_TITLE_QUOTE - Yahoo Finance

Mar 04, 2025
pulisher
Mar 03, 2025

Repare Surprises On Earnings; California Resources Falls Short - Evrim Ağacı

Mar 03, 2025
pulisher
Mar 03, 2025

Why weight-loss drugs are the top target of Medicare price negotiations - Equities News

Mar 03, 2025
pulisher
Feb 19, 2025

Are Investors Inclined To Sell Their Novo Nordisk ADR (NYSE: NVO) Holdings? - Stocks Register

Feb 19, 2025
pulisher
Feb 18, 2025

These 3 Stocks Just Announced Major Dividend Hikes - The Globe and Mail

Feb 18, 2025
pulisher
Feb 17, 2025

Novo Nordisk Shares Near New 52-Week Low: Analysts See Big Upside - The Globe and Mail

Feb 17, 2025

노보 노디스크 (NVO) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading
$179.10
price up icon 2.31%
drug_manufacturers_general JNJ
$154.36
price up icon 1.73%
drug_manufacturers_general NVS
$109.46
price up icon 1.80%
drug_manufacturers_general MRK
$79.17
price down icon 0.01%
$293.92
price up icon 2.78%
자본화:     |  볼륨(24시간):